What does CUSIP 69329YAC8 represent in this 13F holders report?

CUSIP 69329YAC8 is the security identifier for 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 used to aggregate holder disclosures.

How many institutions held 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 in Q2 2014?

21 institutional investors reported 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 for Q2 2014. Use the holders table for investor-level position and value details.

PDL BIOPHARMA INC - NOTE 3.750% 5/0

CUSIP: 69329YAC8

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class: Debt / NOTE 3.750% 5/0
Market price (% of par): 159.71%
Total 13F principal: $161,432,000
Principal change: -$5,411,000
Total reported market value: $258,017,000
Number of holders: 21
Value change: -$7,153,313
Number of buys: 6
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 69329YAC8?
CUSIP 69329YAC8 identifies 69329YAC8 - PDL BIOPHARMA INC - NOTE 3.750% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2014
Previous quarter: Q1 2014

Recent filing periods for CUSIP 69329YAC8:

Q2 2015 Q1 2015 Q4 2014 Q3 2014 Q2 2014 Q1 2014 Q4 2013 Q3 2013

Institutional Holders of PDL BIOPHARMA INC - NOTE 3.750% 5/0 as of Q2 2014

As of 30 Jun 2014, PDL BIOPHARMA INC - NOTE 3.750% 5/0 was held by 21 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $161,432,000 in principal (par value) of the bond. The largest 10 bondholders included WHITEBOX ADVISORS LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, WOLVERINE ASSET MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, LAZARD ASSET MANAGEMENT LLC, Castle Creek Arbitrage, LLC, BlackRock Institutional Trust Company, N.A., GUARDIAN LIFE INSURANCE CO OF AMERICA, and PALISADE CAPITAL MANAGEMENT LLC/NJ. This page lists 21 institutional bondholders reporting positions for the Q2 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price (% of par)	Principal	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.